Graham, J., Wells, J. C., Dudani, S., Gan, C. L., Donskov, F., Lee, J. L., Kollmannsberger, C. K., Meza, L., Beuselinck, B., Hansen, A., North, S. A., Bjarnason, G. A., Sayegh, N., Kanesvaran, R., Wood, L. A., Hotte, S. J., McKay, R. R., Choueiri, T. K., & Heng, D. Y. C. (2022). Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy. European Journal of Cancer, 171, 124-132. https://doi.org/10.1016/j.ejca.2022.05.002
Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy. / Graham, Jeffrey; Wells, John Connor; Dudani, Shaan et al.
In:
European Journal of Cancer, Vol. 171, 08.2022, p. 124-132.
Research output: Contribution to journal › Article › peer-review
Graham, J, Wells, JC, Dudani, S, Gan, CL, Donskov, F, Lee, JL, Kollmannsberger, CK, Meza, L, Beuselinck, B, Hansen, A, North, SA, Bjarnason, GA, Sayegh, N, Kanesvaran, R, Wood, LA, Hotte, SJ, McKay, RR, Choueiri, TK & Heng, DYC 2022, 'Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy', European Journal of Cancer, vol. 171, pp. 124-132. https://doi.org/10.1016/j.ejca.2022.05.002
Graham J, Wells JC, Dudani S, Gan CL, Donskov F, Lee JL et al. Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy. European Journal of Cancer. 2022 Aug;171:124-132. doi: 10.1016/j.ejca.2022.05.002
Graham, Jeffrey ; Wells, John Connor ; Dudani, Shaan et al. / Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy. In: European Journal of Cancer. 2022 ; Vol. 171. pp. 124-132.
@article{53ee48ecbfeb4936b3f220bcf9c7c165,
title = "Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy",
keywords = "Immune checkpoint inhibitor, Immunotherapy, Kidney cancer, Non-clear cell RCC, Renal cell carcinoma, Variant histology RCC",
author = "Jeffrey Graham and Wells, {John Connor} and Shaan Dudani and Gan, {Chun L.} and Frede Donskov and Lee, {Jae lyun} and Kollmannsberger, {Christian K.} and Luis Meza and Benoit Beuselinck and Aaron Hansen and North, {Scott A.} and Bjarnason, {Georg A.} and Nicolas Sayegh and Ravindran Kanesvaran and Wood, {Lori A.} and Hotte, {Sebastien J.} and McKay, {Rana R.} and Choueiri, {Toni K.} and Heng, {Daniel Y.C.}",
note = "Publisher Copyright: {\textcopyright} 2022 Elsevier Ltd",
year = "2022",
month = aug,
doi = "10.1016/j.ejca.2022.05.002",
language = "English",
volume = "171",
pages = "124--132",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Limited",
}
TY - JOUR
T1 - Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy
AU - Graham, Jeffrey
AU - Wells, John Connor
AU - Dudani, Shaan
AU - Gan, Chun L.
AU - Donskov, Frede
AU - Lee, Jae lyun
AU - Kollmannsberger, Christian K.
AU - Meza, Luis
AU - Beuselinck, Benoit
AU - Hansen, Aaron
AU - North, Scott A.
AU - Bjarnason, Georg A.
AU - Sayegh, Nicolas
AU - Kanesvaran, Ravindran
AU - Wood, Lori A.
AU - Hotte, Sebastien J.
AU - McKay, Rana R.
AU - Choueiri, Toni K.
AU - Heng, Daniel Y.C.
N1 - Publisher Copyright:
© 2022 Elsevier Ltd
PY - 2022/8
Y1 - 2022/8
KW - Immune checkpoint inhibitor
KW - Immunotherapy
KW - Kidney cancer
KW - Non-clear cell RCC
KW - Renal cell carcinoma
KW - Variant histology RCC
UR - http://www.scopus.com/inward/record.url?scp=85132341096&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85132341096&partnerID=8YFLogxK
U2 - 10.1016/j.ejca.2022.05.002
DO - 10.1016/j.ejca.2022.05.002
M3 - Article
C2 - 35717820
AN - SCOPUS:85132341096
SN - 0959-8049
VL - 171
SP - 124
EP - 132
JO - European Journal of Cancer
JF - European Journal of Cancer
ER -
